Skip to main content
. 2021 Jun 29;10(13):2905. doi: 10.3390/jcm10132905

Table 5.

The relationship between markers of bone turnover and osteoclastogenesis markers as well as PINP/CTX-I, sRANKL/OPG ratios, and clinical and laboratory indicators of disease activity in women with rheumatoid arthritis at the baseline and after 15 months of anti-TNF-α therapy.

Parameter RA Patients (n = 31)
Time after Initiation of TNFαI Therapy
Baseline (T0)
PINP CTX-I PINP/CTX-I sRANKL OPG sRANKL/OPG
CRP −0.167 NS −0.216 NS 0.03 NS 0.238 NS −0.05 NS 0.302 NS
ESR 0.044 NS −0.075 NS 0.213 NS 0.247 NS 0.233 NS 0.176 NS
DAS28-ESR 0.012 NS −0.216 NS 0.132 NS −0.221 NS 0.07 NS −0.207 NS
SJC −0.130 NS −0.223 NS 0.068 NS −0.307 NS 0.001 NS −0.305 NS
TJC −0.027 NS 0.0245 NS −0.088 NS −0.044 NS −0.236 NS −0.320 NS
VAS 0.105 NS 0.146 NS −0.097 NS −0.047 NS 0.101 NS −0.160 NS
15 Months (T3)
CRP −0.08 NS 0.319 NS −0.333 NS −0.03 NS −0.128 NS 0.059 NS
ESR 0.202 NS 0.067 NS 0.145 NS 0.169 NS 0.285 NS 0.091 NS
DAS28-ESR 0.185 NS 0.112 NS 0.054 NS 0.193 NS 0.255 NS 0.077 NS
SJC 0.353 NS 0.085 NS 0.097 NS 0.000 NS −0.036 NS 0.012 NS
TJC −0.028 NS −0.028 NS 0.0176 NS 0.097 NS −0.214 NS 0.051 NS
VAS 0.082 NS 0.040 NS −0.047 NS 0.071 NS 0.322 NS −0.091 NS

Results are expressed as r (correlation coefficient) according to Spearman rank correlation. Correlations were considered significant at: p < 0.0083 by applying a Bonferroni correction. DAS 28-ESR, disease activity score 28; CTX-I, C-terminal cross-linking telopeptides of type I collagen; ESR, erythrocyte sedimentation rate; NS, not significant; OPG, osteoprotegerin; PINP, N-terminal propeptides of type I procollagen; RA, rheumatoid arthritis; SJC, swollen joint count; sRANKL, total soluble receptor activator of nuclear factor κB ligand; TJC, tender joint count; TNFαΙ, tumor necrosis factor α inhibitors.